Cary Street Partners Investment Advisory LLC Regeneron Pharmaceuticals, Inc. Transaction History
Cary Street Partners Investment Advisory LLC
- $207 Billion
- Q2 2025
A detailed history of Cary Street Partners Investment Advisory LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 349 shares of REGN stock, worth $194,235. This represents 0.09% of its overall portfolio holdings.
Number of Shares
349
Previous 372
6.18%
Holding current value
$194,235
Previous $236 Million
22.34%
% of portfolio
0.09%
Previous 0.14%
Shares
14 transactions
Others Institutions Holding REGN
# of Institutions
1,396Shares Held
87.6MCall Options Held
1.38MPut Options Held
1.37M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.24 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.7 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.15 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.67 Billion0.13% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.13 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $59.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...